Robert S. Wallis

Aurum Institute — South Africa

Medicine · Health Sciences

65h-index14.0kcitations255works5.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(177), Mycobacterium research and diagnosis(91), Infectious Diseases and Tuberculosis(48), Pneumocystis jirovecii pneumonia detection and treatment(45), Diagnosis and treatment of tuberculosis(40)

Publications253 total

Host response biomarkers of tuberculosis recurrence and treatment failure
Communications Medicine·2026Open Access
Correction: Epidemiological factors associated with immunological resistance in household contacts exposed to active tuberculosis in South Africa: A logistic regression analysis
PLoS ONE·2025Open Access
Post TB DNA hypermethylation of an epigenetic network correlates with improved lung function 3769
The Journal of Immunology·2025Open Access
Epidemiological factors associated with immunological resistance in household contacts exposed to active tuberculosis in South Africa: A logistic regression analysis
PLoS ONE·2025· 1 citedOpen Access
Statins for polycystic ovary syndrome in varying resource settings: a phenome-wide association study and evidence synthesis
Frontiers in Pharmacology·2025Open Access
Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial
The Lancet Infectious Diseases·2025· 12 citedOpen Access
Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial
The Lancet Infectious Diseases·2025· 10 citedOpen Access
Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB
Journal of Antimicrobial Chemotherapy·2025· 2 citedOpen Access
DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis
BMC Infectious Diseases·2025· 3 citedOpen Access
panTB-HM: a clinical trial of a pan-TB regimen targeting both host and microbe
2025Open Access
Resistance to tuberculin skin test/interferon-gamma release assay conversion among highly TB exposed, HIV infected goldminers in South Africa
PLoS ONE·2025· 1 citedOpen Access
Neuromyelitis optica causing vision loss during TB treatment with sutezolid: evidence of aberrant immunity following infection
IJTLD OPEN·2025· 1 citedOpen Access
Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial
The Lancet Microbe·2025· 16 citedOpen Access
N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis
Journal of Infection·2025· 6 citedOpen Access
Randomised Trial of a Single Dose of Ad26.COV2.S, BNT162b2 or SARS-CoV-2-rS-PN in Previously Vaccinated and Unvaccinated Adults Living with and without HIV in South Africa: Safety and Immunogenicity
SSRN Electronic Journal·2025Open Access
Tuberculosis Immunotherapy
Elsevier eBooks·2025
TCA metabolism regulates DNA hypermethylation in LPS and<i>Mycobacterium tuberculosis</i>–induced immune tolerance
Proceedings of the National Academy of Sciences·2024· 20 citedOpen Access
Memristors with Monolayer Graphene Electrodes Grown Directly on Sapphire Wafers
ACS Applied Electronic Materials·2024· 4 citedOpen Access
Adjunctive N-Acetylcysteine and Lung Function in Pulmonary Tuberculosis
NEJM Evidence·2024· 20 cited
Economic burden of chronic obstructive pulmonary disease and post-tuberculosis sequelae in low- and middle-income countries: a database compiled from a systematic review and meta-analysis
BMJ Public Health·2024· 1 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Jerrold J. Ellner(12), Alimuddin Zumla(7), Gavin Churchyard(5), Markus Maeurer(5), Michael S. Broder(4), Michael Höelscher(4), Jeremiah Chakaya(4), John L. Johnson(4), Alphonse Okwera(4), David O. Beenhouwer(3), Giovanni Battista Migliori(3), Stellah Mpagama(3), Martin Rao(3), Roxana Rustomjee(3), Peter Mwaba(3), Harriet Mayanja‐Kizza(3), W. Henry Boom(3), Stephan Schwander(3), Roy D. Mugerwa(3), Marco Schito(3)